scholarly journals Effect of low-level laser therapy (904 nm) and static stretching in patients with knee osteoarthritis: a protocol of randomised controlled trial

2015 ◽  
Vol 16 (1) ◽  
Author(s):  
Sarah Rubia Ferreira de Meneses ◽  
David John Hunter ◽  
Eunice Young Docko ◽  
Amelia Pasqual Marques
2018 ◽  
Vol 38 (5) ◽  
pp. 785-793 ◽  
Author(s):  
Fernanda Rossi Paolillo ◽  
Alessandra Rossi Paolillo ◽  
Jessica Patrícia João ◽  
Daniele Frascá ◽  
Marcelo Duchêne ◽  
...  

2021 ◽  
Vol 4 (1) ◽  
pp. 19
Author(s):  
Martin Bjørn Stausholm ◽  
Ingvill Fjell Naterstad ◽  
Christian Couppé ◽  
Kjartan Vibe Fersum ◽  
Ernesto Cesar Pinto Leal-Junior ◽  
...  

Physical activity and low-level laser therapy (LLLT) can reduce knee osteoarthritis (KOA) inflammation. We are conducting a randomized placebo-controlled trial to investigate the long-term effectiveness of LLLT combined with strength training (ST) in persons with KOA, since it, to our knowledge, has not been investigated before. Fifty participants were enrolled. LLLT and ST was performed 3 times per week over 3 and 8 weeks, respectively. In the LLLT group, 3 Joules of 904 nm wavelength laser was applied to 15 spots per knee (45 Joules/knee/session). The primary outcomes are pain during movement, at night and at rest (Visual Analogue Scale) and global pain (Knee injury and Osteoarthritis Outcome Score, KOOS) pain subscale. The secondary outcomes are KOOS disability and quality-of-life, analgesic usage, global health change, knee active range of motion, 30 second chair stand, maximum painless isometric knee extension strength, knee pain pressure threshold and real-time ultrasonography-assessed suprapatellar effusion, meniscal neovascularization and femur cartilage thickness. All the outcomes are assessed 0, 3, 8, 26 and 52 weeks post-randomization, except for global health change, which is only evaluated at completed ST. This study features the blinding of participants, assessors and therapists, and will improve our understanding of what occurs with the local pathophysiology, tissue morphology and clinical status of persons with KOA up to a year after the initiation of ST and a higher 904 nm LLLT dose than in any published trial on this topic.


Sign in / Sign up

Export Citation Format

Share Document